Jasper Historical Financial Ratios

JSPRW Stock

USD 0.22 0.01 4.76%

Jasper Therapeutics is lately reporting on over 92 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 1.1 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Jasper Therapeutics financial condition quickly.

Quick Ratio Current Ratio

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jasper Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Jasper Stock please use our How to Invest in Jasper Therapeutics guide.

About Jasper Financial Ratios Analysis

Jasper TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Jasper Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Jasper financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Jasper Therapeutics history.

Jasper Therapeutics Financial Ratios Chart

At this time, Jasper Therapeutics' Quick Ratio is fairly stable compared to the past year. Cash Ratio is likely to climb to 9.14 in 2024, whereas Operating Cash Flow Per Share is likely to drop (5.24) in 2024.

Payables Turnover Cash Per Share Days Payables Outstanding Income Quality

Add Fundamental

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Income Quality

An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.

Most ratios from Jasper Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Jasper Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jasper Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Jasper Stock please use our How to Invest in Jasper Therapeutics guide.At this time, Jasper Therapeutics' Quick Ratio is fairly stable compared to the past year. Cash Ratio is likely to climb to 9.14 in 2024, whereas Operating Cash Flow Per Share is likely to drop (5.24) in 2024.

	2021	2022	2023	2024 (projected)
Current Ratio	10.95	5.91	7.19	9.43
Net Debt To EBITDA	2.63	0.91	1.29	1.23

Current Ratio Net Debt To E B I T D A

Jasper Therapeutics fundamentals Correlations

	Ptb Ratio	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Cash Per Share	Pocfratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio	Return On Tangible Assets	Ev To Free Cash Flow	Earnings Yield	Intangibles To Total Assets	Net Debt To E B I T D A
Ptb Ratio		0.98	-0.19	0.95	-0.75	1.0	0.94	-0.71	-0.98	0.97	-0.98	0.64	-0.74	-0.24	0.76	-0.19	-0.97	0.83	-0.59	-0.83	-0.66	-0.33	-0.83	0.72	0.96	-0.83
Book Value Per Share	0.98		-0.3	0.92	-0.72	0.98	0.92	-0.7	-0.98	0.97	-0.98	0.71	-0.7	-0.19	0.72	-0.13	-0.98	0.91	-0.56	-0.83	-0.69	-0.3	-0.83	0.69	0.98	-0.84
Free Cash Flow Yield	-0.19	-0.3		-0.4	0.51	-0.19	-0.4	0.44	0.35	-0.4	0.37	-0.88	0.53	-0.82	-0.49	-0.86	0.4	-0.58	0.27	0.3	-0.27	0.12	0.3	0.44	-0.17	0.32
Operating Cash Flow Per Share	0.95	0.92	-0.4		-0.93	0.95	1.0	-0.8	-0.98	0.99	-0.98	0.78	-0.92	0.06	0.93	0.11	-0.98	0.81	-0.66	-0.82	-0.38	-0.4	-0.82	0.47	0.84	-0.83
Capex To Depreciation	-0.75	-0.72	0.51	-0.93		-0.75	-0.93	0.79	0.85	-0.87	0.83	-0.8	1.0	-0.37	-1.0	-0.39	0.85	-0.63	0.65	0.69	0.01	0.44	0.69	-0.14	-0.57	0.71
Pb Ratio	1.0	0.98	-0.19	0.95	-0.75		0.94	-0.71	-0.98	0.97	-0.98	0.64	-0.74	-0.24	0.76	-0.19	-0.97	0.83	-0.59	-0.83	-0.66	-0.33	-0.83	0.72	0.96	-0.83
Free Cash Flow Per Share	0.94	0.92	-0.4	1.0	-0.93	0.94		-0.8	-0.98	0.99	-0.97	0.79	-0.92	0.08	0.93	0.12	-0.98	0.8	-0.66	-0.82	-0.36	-0.41	-0.82	0.46	0.83	-0.83
Roic	-0.71	-0.7	0.44	-0.8	0.79	-0.71	-0.8		0.77	-0.78	0.76	-0.7	0.78	-0.21	-0.78	-0.24	0.77	-0.55	0.97	0.32	0.18	-0.18	0.32	-0.24	-0.6	0.34
Inventory Turnover	-0.98	-0.98	0.35	-0.98	0.85	-0.98	-0.98	0.77		-1.0	1.0	-0.76	0.83	0.06	-0.85	0.01	1.0	-0.86	0.63	0.84	0.53	0.36	0.84	-0.59	-0.92	0.85
Net Income Per Share	0.97	0.97	-0.4	0.99	-0.87	0.97	0.99	-0.78	-1.0		-1.0	0.79	-0.85	0.0	0.87	0.05	-1.0	0.87	-0.63	-0.84	-0.49	-0.37	-0.84	0.54	0.9	-0.85
Days Of Inventory On Hand	-0.98	-0.98	0.37	-0.98	0.83	-0.98	-0.97	0.76	1.0	-1.0		-0.77	0.82	0.06	-0.83	0.0	1.0	-0.88	0.62	0.84	0.55	0.35	0.84	-0.59	-0.93	0.85
Payables Turnover	0.64	0.71	-0.88	0.78	-0.8	0.64	0.79	-0.7	-0.76	0.79	-0.77		-0.8	0.55	0.78	0.6	-0.79	0.84	-0.51	-0.64	-0.07	-0.28	-0.64	-0.02	0.58	-0.66
Cash Per Share	-0.74	-0.7	0.53	-0.92	1.0	-0.74	-0.92	0.78	0.83	-0.85	0.82	-0.8		-0.39	-1.0	-0.41	0.83	-0.61	0.64	0.68	-0.02	0.44	0.68	-0.11	-0.55	0.7
Pocfratio	-0.24	-0.19	-0.82	0.06	-0.37	-0.24	0.08	-0.21	0.06	0.0	0.06	0.55	-0.39		0.35	1.0	0.02	0.06	-0.11	0.06	0.77	-0.1	0.06	-0.84	-0.36	0.04
Capex To Operating Cash Flow	0.76	0.72	-0.49	0.93	-1.0	0.76	0.93	-0.78	-0.85	0.87	-0.83	0.78	-1.0	0.35		0.37	-0.84	0.62	-0.65	-0.69	-0.01	-0.45	-0.69	0.15	0.57	-0.71
Pfcf Ratio	-0.19	-0.13	-0.86	0.11	-0.39	-0.19	0.12	-0.24	0.01	0.05	0.0	0.6	-0.41	1.0	0.37		-0.03	0.13	-0.13	0.02	0.72	-0.1	0.02	-0.8	-0.3	0.0
Days Payables Outstanding	-0.97	-0.98	0.4	-0.98	0.85	-0.97	-0.98	0.77	1.0	-1.0	1.0	-0.79	0.83	0.02	-0.84	-0.03		-0.89	0.62	0.84	0.52	0.35	0.84	-0.56	-0.92	0.85
Income Quality	0.83	0.91	-0.58	0.81	-0.63	0.83	0.8	-0.55	-0.86	0.87	-0.88	0.84	-0.61	0.06	0.62	0.13	-0.89		-0.35	-0.84	-0.56	-0.36	-0.84	0.45	0.87	-0.84
Roe	-0.59	-0.56	0.27	-0.66	0.65	-0.59	-0.66	0.97	0.63	-0.63	0.62	-0.51	0.64	-0.11	-0.65	-0.13	0.62	-0.35		0.11	0.15	-0.37	0.11	-0.24	-0.49	0.13
Ev To Operating Cash Flow	-0.83	-0.83	0.3	-0.82	0.69	-0.83	-0.82	0.32	0.84	-0.84	0.84	-0.64	0.68	0.06	-0.69	0.02	0.84	-0.84	0.11		0.48	0.77	1.0	-0.51	-0.79	1.0
Pe Ratio	-0.66	-0.69	-0.27	-0.38	0.01	-0.66	-0.36	0.18	0.53	-0.49	0.55	-0.07	-0.02	0.77	-0.01	0.72	0.52	-0.56	0.15	0.48		0.0	0.48	-0.94	-0.82	0.46
Return On Tangible Assets	-0.33	-0.3	0.12	-0.4	0.44	-0.33	-0.41	-0.18	0.36	-0.37	0.35	-0.28	0.44	-0.1	-0.45	-0.1	0.35	-0.36	-0.37	0.77	0.0		0.77	-0.1	-0.23	0.77
Ev To Free Cash Flow	-0.83	-0.83	0.3	-0.82	0.69	-0.83	-0.82	0.32	0.84	-0.84	0.84	-0.64	0.68	0.06	-0.69	0.02	0.84	-0.84	0.11	1.0	0.48	0.77		-0.51	-0.79	1.0
Earnings Yield	0.72	0.69	0.44	0.47	-0.14	0.72	0.46	-0.24	-0.59	0.54	-0.59	-0.02	-0.11	-0.84	0.15	-0.8	-0.56	0.45	-0.24	-0.51	-0.94	-0.1	-0.51		0.8	-0.49
Intangibles To Total Assets	0.96	0.98	-0.17	0.84	-0.57	0.96	0.83	-0.6	-0.92	0.9	-0.93	0.58	-0.55	-0.36	0.57	-0.3	-0.92	0.87	-0.49	-0.79	-0.82	-0.23	-0.79	0.8		-0.79
Net Debt To E B I T D A	-0.83	-0.84	0.32	-0.83	0.71	-0.83	-0.83	0.34	0.85	-0.85	0.85	-0.66	0.7	0.04	-0.71	0.0	0.85	-0.84	0.13	1.0	0.46	0.77	1.0	-0.49	-0.79

Click cells to compare fundamentals

Jasper Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Price Book Value Ratio	Price Earnings To Growth Ratio
Days Of Payables Outstanding	Dividend Payout Ratio
Price To Operating Cash Flows Ratio	Price To Free Cash Flows Ratio
Pretax Profit Margin	Ebt Per Ebit
Operating Profit Margin	Effective Tax Rate
Company Equity Multiplier	Long Term Debt To Capitalization
Total Debt To Capitalization	Return On Capital Employed
Debt Equity Ratio	Ebit Per Revenue
Quick Ratio	Dividend Paid And Capex Coverage Ratio
Net Income Per E B T	Cash Ratio
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Jasper Historical Financial Ratios

About Jasper Financial Ratios Analysis

Jasper Therapeutics Financial Ratios Chart

Payables Turnover

Income Quality

Jasper Therapeutics fundamentals Correlations

Jasper Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Jasper Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Cash Per Share	+ 1.0	Capex To Depreciation
Days Of Inventory On Hand	+ 1.0	Inventory Turnover
Days Payables Outstanding	+ 1.0	Inventory Turnover
Days Payables Outstanding	+ 1.0	Days Of Inventory On Hand

Capex To Operating Cash Flow	- 1.0	Cash Per Share
Days Payables Outstanding	- 1.0	Net Income Per Share
Days Of Inventory On Hand	- 1.0	Net Income Per Share
Net Income Per Share	- 1.0	Inventory Turnover
Capex To Operating Cash Flow	- 1.0	Capex To Depreciation
Days Payables Outstanding	- 0.98	Free Cash Flow Per Share